EP0791062A1 - Die genexpression in coryneformen bakterien regulierende dna - Google Patents
Die genexpression in coryneformen bakterien regulierende dnaInfo
- Publication number
- EP0791062A1 EP0791062A1 EP95936429A EP95936429A EP0791062A1 EP 0791062 A1 EP0791062 A1 EP 0791062A1 EP 95936429 A EP95936429 A EP 95936429A EP 95936429 A EP95936429 A EP 95936429A EP 0791062 A1 EP0791062 A1 EP 0791062A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- protein
- dna fragment
- acetate
- cgc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Definitions
- the invention relates to a DNA regulating gene expression in coryneform bacteria.
- Corynebacterium glutamicu and the species closely related to it are c. mela ⁇ ecolae, Brevibacterium flavum and B. lactofermentum counted among the coryneform bacteria. Furthermore, the mentioned species to the 'glutamic acid bacteria' because they are able to excrete large amounts of glutamate into the medium under certain growth conditions. The microorganisms mentioned are of great industrial interest since they can be used for the production of amino acids, purines and proteins. For C. glutamicum, C. mela ⁇ secolae, B. flavum and B.
- lactofermentum growth on acetate or ethanol has already been demonstrated and it has been shown that they have a glyoxylate cycle, ie also the enzymes isocitrate lyase and malate synthase, (For an overview see: Kinoshita, Amino acids, in Biology of industrial organisms, 1985, pp. 115-142, Benjamin / cum ings Publishing).
- coryneform bacteria can be genetically modified for specific purposes.
- the genes to be cloned are cloned under the control of their own promoters onto vectors which are present in high copy numbers in coryneform bacteria. It was shown in several cases that a strong overexpression of individual genes had an adverse effect on the growth of coryneform bacteria and thus on the production of desired products. The reason for this was that the
- a desired gene can be integrated into the chromosome of coryneform bacteria in a single copy number. Since there is only one copy of this gene in the organism, there are usually no toxic effects from the corresponding gene product. A weakness of this method lies in the labor-intensive methodology to achieve the desired goal. In addition, the simple copy number of the inserted gene rarely produces a sufficient amount of a desired substance.
- An alternative to integrating a gene into the chromosome of coryneform bacteria is to clone a gene onto a low copy vector in coryneform bacteria. This has the advantage that the corresponding gene product is formed in a relatively small amount and is therefore usually not toxic to the cell. Allerdin ⁇ s is too in this case the relatively small amount of gene product for biotechnological applications is a disadvantage.
- each of the three promoters needs to induce a gene are relatively uninteresting for industrial purposes.
- the lac promoter requires the relatively expensive substance IPTG to induce a gene, which renders a large-scale application of this promoter unprofitable.
- IPTG IPTG
- Lambda P L is activated by heat. Heat not only damages the organism but could also have a harmful effect on the product formed, so that this promoter is of no industrial interest for coryneform bacteria 5 is.
- the trp promoter is activated by tryptophan deficiency. Since coryneform bacteria usually do not suffer from tryptophan deficiency, the use of this promoter would require the production of coryneform tryptophan deficiency mutants. Since the generation of such mutants is relatively complex, the trp promoter has not yet found its way into the biotechnological use of coryneform bacteria.
- the ideal case for a regulatable promoter was a coryneform promoter, which is regulated by an easily available, inexpensive substance.
- the only coryneform promoter described so far is that of the gene for isocitrate lyase (EP-OS 0 530 765).
- This promoter leads to the expression of genes as long as there is no sugar in the medium.
- sugar since sugar is used as a carbon source in most fermentation media, it would make sense to obtain a regulable promoter which also leads to the expression of a gene in the presence of sugars with an inexpensive inducer.
- the expression of the malate synthase gene in coryneform bacteria can be induced by the presence of inducers such as lactate, pyruvate and / or acetate.
- inducers such as lactate, pyruvate and / or acetate.
- This induction in particular through acetate, also occurs when there are other carbon sources in the medium. Even in the presence of sugars or in complex medium there is significant induction by acetate.
- Inducer such as acetate and regardless of the composition of the fermentation medium to express genes regulated in coryneform bacteria.
- the malate synthase gene of the present invention is a malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of the malate synthase gene of
- Coryjie ⁇ acter UJD glutamicum upstream and isolated from this DNA fragment provided; i.e. the gene for malate synthase (aceB) was isolated and sequenced from C-glutamicum together with the structures required for expression and regulation.
- the DNA sequence and the amino acid sequence derived from it are shown in Table 2.
- the ribosome binding site of the aceB gene is underlined and marked with 'RBS'.
- the potential terminator of aceB transcription is shown by antiparallel arrows.
- the media used were 2xTY complete medium or CgC minimal medium (Eikmanns et al., Appl Microbiol Biotechnol 34 (1991) 617-622), each with 1% of glucose, acetate, pyruvate, lactate, citrate, succinate , Fumarate or glutamate used as a carbon source.
- the cultures were incubated again at 30 ° C and the OD 60Q was followed.
- the cells Upon reaching an OD of 60 o 8 ⁇ 10, the cells were harvested by centrifugation, washed once with buffer pH 7.6 (50 mM Tris / HCl), resuspended in 1 ml of the same buffer was added, and by sonication in a Branson Sonifier W250 (10 Minutes, pulsed with an interval of 20% and an output of 30 watts). To separate the cell debris, the homogenate was sigma at 13000 rpm for 30 minutes
- the enzyme test contained in a final volume of 1.0 ml, 50 mM
- the mixture was incubated at 30 ° C., the decrease in extinction at 232 nm was determined over a period of 2 minutes, which decrease results from the cleavage of the thioester bond of acetyl-CoA.
- the extinction coefficient of acetyl-CoA at 232 nm is 4.5 mM -1 cm -1 (Stadtman, Methods in Enzy ology, Vol. 3, 1957, New York: Academic Press).
- the protein content of the crude extracts was determined using the biuret method (Bradford, Anal Biochem 72 (1976) 248-254).
- the specific malate synthase activities obtained are listed in Table 1.
- Table 1 the activity of the MSY when growing on 2xTY complete medium and on CgC minimal medium with glucose, citrate, succinate, fumarate or glutamate as a carbon source is approximately 0.04 U / mg protein.
- CgC minimal medium with lactate or pyruvate as carbon sources the MSY activity increases to values of 0.173 U / mg protein or 0.192 U / mg protein. The highest MSY activity is observed with 2.212 U / mg protein when growing on CgC minimal medium with acetate.
- coli stam ED8654 (Murray et al. Mol Gen Genet 150 (1977) 53-61) was transfected therewith.
- the recombinant cosmids were packaged in the protein envelope of the phage lambda by a method by Sternberg et al. (Gene 1 (1979) 255-280), the transfection of E. coli ED8654 according to a method by Sambrook et al. (Molecular Cloning, A Laboratory Handbook, 1989, Cold Spring Harbor Laboratory Press).
- the corresponding cosmids were isolated from a total of 30 of the recombinant E.
- mutant DV21A05 (anderwinkel and De Vlieghere Eur J Biochem 5 (1968) 81-90) according to a known method (Sambrook et al., Molecular Cloning, A Laboratory Handbook, 1989, Cold Spring Harbor Laboratory Press). Due to its MSY defect, mutant DV21A05 is no longer able to grow on acetate as the only carbon source. After transformation of the Cosmid gene bank into this mutant, a total of 1000 clones were obtained. Of these, three clones showed growth on M9 minimal medium (Sambrook et al., Molecular Cloning, A Laboratory Handbook, 1989, Cold Spring Harbor Laboratory Press) with acetate as the only carbon source. After isolating the corresponding cosmids (Sambrook et al.,
- the plasmids generated in this way were used to generate deletion constructs according to the method of Henikoff (Gene 28 (1984) 351-359), which were subsequently used by the chain termination sequencing method (Sanger et al., Proc Natl Acad Sei USA, 74 (1977) 5463-5467) were sequenced.
- the entire sequence of the 3 kb Bfrl-Pvul fragment obtained in this way is shown in Table 2.
- the protein sequence derived from the aceB gene for the MSY from C. glutamicum, the ribosome binding site located in front of the gene and the termination structure for the transcription behind the gene are shown in Table 2.
- Electroporation (Liebl et al., FEMS Microbiol Lett 65 (1989) 299-304) was used to isolate the plasmids pEKBla and pEKBlb in C. introduced glutamicum and the resulting strains as WT (pEKBla) and WT (pEKBlb) called.
- WT pEKBla
- WT pEKBlb
- the newly constructed C. glutamicum strains were grown on CgC minimal medium with glucose, glucose / acetate or acetate as carbon sources up to an OD 60 o of 8-10, crude extracts were prepared and the specific MSY activity was determined in them .
- the measured MSY activities are shown in Table 3.
- This result proves that on the 3 kb Bfrl-Pvul fragment the aceB gene from C. Functionally available glutamicum.
- aceB gene required structures, ie the promoter and regulatory sequences, are located. These structures are in front of the aceB gene. Since the cloned fragment still bears 584 bp before the actual aceB structural gene (see Table 2), the structures for expression and regulation must be located in this DNA region. 5. Studies on the regulation and expression of the aceB gene from C glutamicum.
- MSY accounts for approximately 20% of the total cell protein in this strain.
- the result shows that the structures necessary for the expression and regulation of aceB induce the re-synthesis of large amounts of protein under induced conditions.
- the result shows that the observed increase in MSY activity after growth on acetate is due to the new synthesis of the MSY protein.
- the DNA region in front of the aceB gene was isolated according to known methods as a 574 bp Bfrl-DraJ fragment, the overhanging ends were filled in to blunt ends with Klenow polymerase and into the Sall interface of the vector pEKplCm (Eikmanns.) Filled in with Klenow polymerase et al., Gene 102 (1991) 93-98).
- This plasmid carries the chloramphenicol acetyltransferase gene (cat) behind the insertion site, but without its own promoter, ie the cat gene in C. glutamicum cannot be read from the plasmid pEKplCm.
- the strains to be investigated were cultivated according to a known method on the above-mentioned media up to an OD 60 o 8 to 10, crude extracts were prepared and in these the specific CAT activity according to the method of Shaw (Meth Enzymol 43 (1975) 737-755).
- the test contained in a final volume of 1.0 ml 100 mM Tris / HCl pH 7.8, 1 mM acetyl-coenzyme A, 1 mM 5,5-dithiobis (2-nitrobenzoic acid) and crude extract and was treated with 2.5 mM chloramphenicol started. The mixture was incubated at 30 ° C. The increase in absorbance at 412 nm was determined over a period of 2 minutes.
- the protein content of the crude extracts was determined using the biuret method (Bradford, Anal Biochem 72 (1976) 248-254).
- the specific CAT activities obtained are listed in Table 4. While there was no CAT activity detected in the C. glutamicum WT under any of the conditions tested, the recombinant strain C. glutamicum WT (pIWI) showed CAT activity for all carbon sources. However, the CAT activity after growth on CgC glucose was about 20 times lower than after growth on CgC glucose / acetate and even 50 times lower than after growth on CgC acetate. This result confirms that the isolated 574 bp Bfrl-Dral fragment allows the regulated gene expression of foreign genes. The foreign gene is induced by acetate, even in the presence of sugar.
- the supernatant was chromatographed on an FPLC system with an HR5 / 5 MonoQ anion exchange column (Pharmacia LKB, Freiburg Germany).
- the MSY was eluted with a 0.1 M to 0.4 M NaCl gradient in 50 mM MES / NaOH pH 6.
- the buffer of the partially purified MSY was changed from 50 mM MES / NaOH pH 6 to 50 mM Tris / HCl pH 8 by means of ultrafiltration.
- MSY malate synthase
- Table 4 Specific activity of chloramphenicol acetyltransferase (CAT) in crude extracts of the C. glutamicum wild type (WT) and the recombinant C. glutamicum strain WT (pIWI) after growth on CgC minimal medium with glucose, glucose / acetate or acetate as Carbon sources.
- CAT chloramphenicol acetyltransferase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4440118A DE4440118C1 (de) | 1994-11-11 | 1994-11-11 | Die Genexpression in coryneformen Bakterien regulierende DNA |
DE4440118 | 1994-11-11 | ||
PCT/DE1995/001555 WO1996015246A1 (de) | 1994-11-11 | 1995-11-07 | Die genexpression in coryneformen bakterien regulierende dna |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0791062A1 true EP0791062A1 (de) | 1997-08-27 |
Family
ID=6532942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95936429A Withdrawn EP0791062A1 (de) | 1994-11-11 | 1995-11-07 | Die genexpression in coryneformen bakterien regulierende dna |
Country Status (8)
Country | Link |
---|---|
US (1) | US5965391A (zh) |
EP (1) | EP0791062A1 (zh) |
JP (1) | JPH10512742A (zh) |
KR (1) | KR970707269A (zh) |
CN (1) | CN1174574A (zh) |
DE (1) | DE4440118C1 (zh) |
WO (1) | WO1996015246A1 (zh) |
ZA (1) | ZA959598B (zh) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797509B1 (en) | 1999-07-09 | 2004-09-28 | Degussa-Huls Ag | Nucleotide sequences which code for the tal gene |
US20060014259A9 (en) * | 1999-07-09 | 2006-01-19 | Kevin Burke | Process for the preparation of L-amino acids with amplification of the zwf gene |
US6927046B1 (en) * | 1999-12-30 | 2005-08-09 | Archer-Daniels-Midland Company | Increased lysine production by gene amplification using coryneform bacteria |
US20050112733A1 (en) * | 2000-03-20 | 2005-05-26 | Degussa Ag | Process for the preparation of L-amino acids with amplification of the zwf gene |
US20030175911A1 (en) * | 2000-03-20 | 2003-09-18 | Stephen Hans | Process for the preparation of L-amino acids with amplification of the zwf gene |
DE10109690A1 (de) | 2000-09-02 | 2002-03-14 | Degussa | Neue für das metY-Gen kodierende Nukleotidsequenzen |
WO2002040679A2 (en) * | 2000-11-15 | 2002-05-23 | Archer-Daniels-Midland Company | Corynebacterium glutamicum promoters |
WO2003012395A2 (en) * | 2001-08-02 | 2003-02-13 | New York University | Early detection of mycobacterial disease using peptides |
DE10217058A1 (de) | 2002-04-17 | 2003-11-27 | Basf Ag | Verfahren zur Herstellung von schwefelhaltigen Feinchemikalien |
EP1362866A1 (en) * | 2002-05-16 | 2003-11-19 | Basf Aktiengesellschaft | Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum |
DE10222858A1 (de) | 2002-05-23 | 2003-12-04 | Basf Ag | Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien |
DE10239073A1 (de) * | 2002-08-26 | 2004-03-11 | Basf Ag | Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien |
DE10239082A1 (de) | 2002-08-26 | 2004-03-04 | Basf Ag | Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien |
DE10239308A1 (de) * | 2002-08-27 | 2004-03-11 | Basf Ag | Verfahren zur fermentativen Herstellung von schwefelhaltigen Feinchemikalien |
WO2005007862A2 (en) | 2003-07-08 | 2005-01-27 | Novus Internation, Inc | Methionine recovery processes |
DE10359595A1 (de) | 2003-12-18 | 2005-07-28 | Basf Ag | Pgro-Expressionseinheiten |
US8728795B2 (en) | 2003-12-18 | 2014-05-20 | Basf Se | Pgro expression units |
DE10359660A1 (de) | 2003-12-18 | 2005-07-28 | Basf Ag | Psod-Expressionseinheiten |
DE10359594A1 (de) | 2003-12-18 | 2005-07-28 | Basf Ag | PEF-TU-Expressionseinheiten |
DE102004035065A1 (de) | 2004-07-20 | 2006-02-16 | Basf Ag | P-ET-TS-Expressionseinheiten |
DE102004055414A1 (de) | 2004-11-17 | 2006-05-24 | Degussa Ag | Allele des metK-Gens aus coryneformen Bakterien |
DE102004061846A1 (de) | 2004-12-22 | 2006-07-13 | Basf Ag | Mehrfachpromotoren |
US20070092951A1 (en) * | 2005-03-24 | 2007-04-26 | Degussa Ag | Alleles of the zwf gene from coryneform bacteria |
DE102005019967A1 (de) * | 2005-04-29 | 2006-11-02 | Forschungszentrum Jülich GmbH | Verfahren zur fermentativen Herstellung von L-Aminosäuren |
DE102005047596A1 (de) | 2005-10-05 | 2007-04-12 | Degussa Ag | Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien |
DE102005048818A1 (de) | 2005-10-10 | 2007-04-12 | Degussa Ag | Mikrobiologische Herstellung von 3-Hydroxypropionsäure |
RU2009134796A (ru) | 2007-02-19 | 2011-03-27 | Эвоник Дегусса ГмБх (DE) | Коринеформные бактерии, обладающие формиат-тгф-синтетазной активностью и/или активностью в отношении расщепления глицина |
DE102007015583A1 (de) | 2007-03-29 | 2008-10-02 | Albert-Ludwigs-Universität Freiburg | Ein Enzym zur Herstellung von Methylmalonyl-Coenzym A oder Ethylmalonyl-Coenzym A sowie dessen Verwendung |
DE102007027006A1 (de) | 2007-06-08 | 2008-12-11 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Aldehyden, insbesondere von 3-Hydroxypropionaldehyd |
DE102007041862A1 (de) | 2007-09-03 | 2009-03-19 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Isoprenoiden |
DE102007059248A1 (de) | 2007-12-07 | 2009-06-10 | Albert-Ludwigs-Universität Freiburg | Zelle, welche in der Lage ist, CO2 zu fixieren |
DE102007060705A1 (de) | 2007-12-17 | 2009-06-18 | Evonik Degussa Gmbh | ω-Aminocarbonsäuren oder ihre Lactame, herstellende, rekombinante Zellen |
CN101981202B (zh) | 2008-01-23 | 2013-09-11 | 巴斯夫欧洲公司 | 发酵生产1,5-二氨基戊烷的方法 |
KR100987281B1 (ko) | 2008-01-31 | 2010-10-12 | 씨제이제일제당 (주) | 개량된 프로모터 및 이를 이용한 l-라이신의 생산 방법 |
DE102008002715A1 (de) | 2008-06-27 | 2009-12-31 | Evonik Röhm Gmbh | 2-Hydroxyisobuttersäure produzierende rekombinante Zelle |
DE102008041299A1 (de) | 2008-08-18 | 2010-02-25 | Evonik Degussa Gmbh | Neuartiges, universell einsetzbares addiction-System |
DE102008054918A1 (de) | 2008-12-18 | 2010-07-01 | Evonik Degussa Gmbh | Verfahren zur enzymatischen Umsetzung von Alkanen |
KR20100117465A (ko) | 2009-04-24 | 2010-11-03 | 삼성전자주식회사 | 호스트셀의 알코올 내성을 증대시키는 단리된 폴리뉴클레오티드, 이를 포함하는 벡터, 호스트셀 및 이를 이용한 알코올의 생산방법 |
DE102010014680A1 (de) | 2009-11-18 | 2011-08-18 | Evonik Degussa GmbH, 45128 | Zellen, Nukleinsäuren, Enzyme und deren Verwendung sowie Verfahren zur Herstellung von Sophorolipiden |
KR101174267B1 (ko) * | 2010-01-06 | 2012-08-14 | 씨제이제일제당 (주) | L-오르니틴 또는 l-아르기닌 생산 변이주 및 이의 제조방법 |
DE102010019059A1 (de) | 2010-05-03 | 2011-11-03 | Forschungszentrum Jülich GmbH | Sensoren zur intrazellulären Metabolit-Detektion |
DE102010029973A1 (de) | 2010-06-11 | 2011-12-15 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von C4-Körpern aus Saccharose und Kohlendioxid |
DE102010032484A1 (de) | 2010-07-28 | 2012-02-02 | Evonik Goldschmidt Gmbh | Zellen und Verfahren zur Herstellung von Rhamnolipiden |
EP2479279A1 (de) | 2011-01-20 | 2012-07-25 | Evonik Degussa GmbH | Verfahren zur fermentativen Herstellung schwefelhaltiger Aminosäuren |
RU2011134436A (ru) | 2011-08-18 | 2013-10-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, обладающей повышенной экспрессией генов каскада образования флагелл и клеточной подвижности |
DE102012201360A1 (de) | 2012-01-31 | 2013-08-01 | Evonik Industries Ag | Zellen und Verfahren zur Herstellung von Rhamnolipiden |
RU2012112651A (ru) | 2012-04-02 | 2013-10-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | САМОИНДУЦИРУЕМАЯ ЭКСПРЕССИОННАЯ СИСТЕМА И ЕЕ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ПОЛЕЗНЫХ МЕТАБОЛИТОВ С ПОМОЩЬЮ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae |
DE102012007491A1 (de) | 2012-04-11 | 2013-10-17 | Evonik Industries Ag | Neue Enzyme |
RU2550269C2 (ru) | 2012-08-17 | 2015-05-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | СПОСОБ ПОЛУЧЕНИЯ L-АРГИНИНА С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae, СОДЕРЖАЩЕЙ N-АЦЕТИЛОРНИТИНДЕАЦЕТИЛАЗУ С НАРУШЕННОЙ АКТИВНОСТЬЮ |
EP2700715B1 (de) | 2012-08-20 | 2018-07-25 | Evonik Degussa GmbH | Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae |
DE102013202106A1 (de) | 2013-02-08 | 2014-08-14 | Evonik Industries Ag | Autotrophe Kultivierung |
RU2013118637A (ru) | 2013-04-23 | 2014-10-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА ENTEROBACTERIACEAE, В КОТОРОЙ РАЗРЕГУЛИРОВАН ГЕН yjjK |
EP2811028B1 (de) | 2013-06-03 | 2017-02-01 | Evonik Degussa GmbH | Verfahren zur Herstellung von L-Valin unter Verwendung rekombinanter Corynebakterien enthaltend das durch Propionat induzierbare ilvBN-Operon |
RU2013140115A (ru) | 2013-08-30 | 2015-03-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae, В КОТОРОЙ НАРУШЕНА ЭКСПРЕССИЯ КЛАСТЕРА ГЕНОВ znuACB |
RU2013144250A (ru) | 2013-10-02 | 2015-04-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА Enterobacteriaceae, В КОТОРОЙ ОСЛАБЛЕНА ЭКСПРЕССИЯ ГЕНА, КОДИРУЮЩЕГО ФОСФАТНЫЙ ТРАНСПОРТЕР |
EP2860256B1 (en) | 2013-10-11 | 2017-03-08 | CJ Cheiljedang Corporation | Method of producing l-amino acids |
RU2013147882A (ru) | 2013-10-28 | 2015-05-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИЙ СЕМЕЙСТВА Enterobacteriaceae, В КОТОРОЙ НАРУШЕН ПУТЬ ДЕГРАДАЦИИ ПУТРЕСЦИНА |
DE102014201384A1 (de) | 2014-01-27 | 2015-07-30 | Evonik Industries Ag | Verfahren umfassend eine Kultivierung unter niedriger Gelöstsauerstoffkonzentration |
RU2014105547A (ru) | 2014-02-14 | 2015-08-20 | Адзиномото Ко., Инк. | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ С ИСПОЛЬЗОВАНИЕМ БАКТЕРИИ СЕМЕЙСТВА ENTEROBACTERIACEAE, ИМЕЮЩЕЙ СВЕРХЭКСПРЕССИРУЕМЫЙ ГЕН yajL |
LU92409B1 (en) | 2014-03-21 | 2015-09-22 | Philipps Universit T Marburg | Means and methods for itaconic acid production |
CN106661541B (zh) | 2014-04-17 | 2021-09-03 | 贝林格尔·英格海姆Rcv两合公司 | 被工程化为过表达辅助蛋白的重组宿主细胞 |
JP2017511147A (ja) | 2014-04-17 | 2017-04-20 | ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 目的タンパク質を発現させるための組換え宿主細胞 |
EP2949214A1 (en) | 2014-05-26 | 2015-12-02 | Evonik Degussa GmbH | Methods of producing rhamnolipids |
EP2952584A1 (en) | 2014-06-04 | 2015-12-09 | Boehringer Ingelheim RCV GmbH & Co KG | Improved protein production |
CN107208123A (zh) | 2015-02-19 | 2017-09-26 | 赢创德固赛有限公司 | 鼠李糖脂合成 |
ES2758096T3 (es) | 2015-03-25 | 2020-05-04 | Senseup Gmbh | Sensores para la detección y cuantificación de secreción microbiológica de proteínas |
RU2015114955A (ru) | 2015-04-22 | 2016-11-10 | Аджиномото Ко., Инк. | Способ получения L-изолейцина с использованием бактерии семейства Enterobacteriaceae, в которой сверхэкспрессирован ген cycA |
RU2015120052A (ru) | 2015-05-28 | 2016-12-20 | Аджиномото Ко., Инк. | Способ получения L-аминокислоты с использованием бактерии семейства Enterobacteriaceae, в которой ослаблена экспрессия гена gshA |
CA3007635A1 (en) | 2015-12-07 | 2017-06-15 | Zymergen Inc. | Promoters from corynebacterium glutamicum |
US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
BR112018017227A2 (pt) | 2016-02-25 | 2019-02-05 | Ajinomoto Kk | método para produzir um l-aminoácido |
DE102016007810B4 (de) | 2016-06-25 | 2023-12-07 | Forschungszentrum Jülich GmbH | Verfahren zur Herstellung von D-Xylonat |
US10544390B2 (en) | 2016-06-30 | 2020-01-28 | Zymergen Inc. | Methods for generating a bacterial hemoglobin library and uses thereof |
KR102345898B1 (ko) | 2016-06-30 | 2022-01-03 | 지머젠 인코포레이티드 | 글루코오스 투과 효소 라이브러리를 생성하는 방법 및 이의 용도 |
US20190233856A1 (en) | 2016-10-24 | 2019-08-01 | Evonik Degussa Gmbh | Cells and method for producing rhamnolipids using alternative glucose transporters |
WO2018077700A1 (en) | 2016-10-24 | 2018-05-03 | Evonik Degussa Gmbh | Rhamnolipid-producing cell having reduced glucose dehydrogenase activity |
SG10202110774QA (en) | 2017-03-29 | 2021-11-29 | Boehringer Ingelheim Rcv Gmbh | Recombinant host cell with altered membrane lipid composition |
US20200239897A1 (en) | 2017-06-07 | 2020-07-30 | Zymergen Inc. | Promoters from corynebacterium glutamicum and uses thereof in regulating ancillary gene expression |
JP7226449B2 (ja) | 2017-12-26 | 2023-02-21 | 味の素株式会社 | 発酵によるグリシンの製造方法 |
JP7411557B2 (ja) | 2018-02-09 | 2024-01-11 | エボニック オペレーションズ ゲーエムベーハー | グルコリピドを含有する混合組成物 |
WO2019212052A1 (en) | 2018-05-04 | 2019-11-07 | Ajinomoto Co., Inc. | METHOD FOR PRODUCING L-METHIONINE USING A BACTERIUM OF THE GENUS Pantoea |
CN112955547A (zh) | 2018-06-27 | 2021-06-11 | 贝林格尔·英格海姆Rcv两合公司 | 通过使用转录因子来增加蛋白质表达的手段和方法 |
DE112019003478A5 (de) | 2018-07-11 | 2021-04-08 | Forschungszentrum Jülich GmbH | D-xylose-dehydrogenase aus coryneformen bakterien und verfahren zur herstellung von d-xylonat |
DE102018117233A1 (de) | 2018-07-17 | 2020-01-23 | Technische Universität Dortmund | Biotechnologische Herstellung von Cannabinoiden |
EP3856918A1 (en) | 2018-09-28 | 2021-08-04 | Ajinomoto Co., Inc. | Method for producing l-methionine using a bacterium |
WO2020071538A1 (en) | 2018-10-05 | 2020-04-09 | Ajinomoto Co., Inc. | Method for producing target substance by bacterial fermentation |
JP7491312B2 (ja) | 2018-12-27 | 2024-05-28 | 味の素株式会社 | 腸内細菌科の細菌の発酵による塩基性l-アミノ酸またはその塩の製造方法 |
WO2020171227A1 (en) | 2019-02-22 | 2020-08-27 | Ajinomoto Co., Inc. | METHOD FOR PRODUCING L-AMINO ACIDS USING A BACTERIUM BELONGING TO THE FAMILY Enterobacteriaceae HAVING OVEREXPRESSED ydiJ GENE |
BR112021017870A2 (pt) | 2019-04-05 | 2021-12-07 | Ajinomoto Kk | Método para produzir um l-aminoácido |
WO2021060438A1 (en) | 2019-09-25 | 2021-04-01 | Ajinomoto Co., Inc. | Method for producing l-amino acids by bacterial fermentation |
DE102021000394A1 (de) | 2021-01-27 | 2022-07-28 | Forschungszentrum Jülich GmbH | Herstellung von 3,4-Dihydroxybenzoat aus D-Xylose mit coryneformen Bakterien |
JP2024506650A (ja) | 2021-02-12 | 2024-02-14 | ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 増加したタンパク質分泌のためのシグナルペプチド |
DE102022004733A1 (de) | 2022-12-15 | 2024-06-20 | Forschungszentrum Jülich GmbH | Genetisch modifizierter Mikroorganismus und dessen Verwendung zur Herstellung von D-Chiro-Inositol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3036912B2 (ja) * | 1991-09-02 | 2000-04-24 | 協和醗酵工業株式会社 | 遺伝子発現調節dna |
-
1994
- 1994-11-11 DE DE4440118A patent/DE4440118C1/de not_active Expired - Fee Related
-
1995
- 1995-11-07 JP JP8515635A patent/JPH10512742A/ja active Pending
- 1995-11-07 WO PCT/DE1995/001555 patent/WO1996015246A1/de not_active Application Discontinuation
- 1995-11-07 EP EP95936429A patent/EP0791062A1/de not_active Withdrawn
- 1995-11-07 CN CN95197304A patent/CN1174574A/zh active Pending
- 1995-11-07 US US08/836,943 patent/US5965391A/en not_active Expired - Fee Related
- 1995-11-07 KR KR1019970703175A patent/KR970707269A/ko not_active Application Discontinuation
- 1995-11-13 ZA ZA959598A patent/ZA959598B/xx unknown
Non-Patent Citations (1)
Title |
---|
See references of WO9615246A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996015246A1 (de) | 1996-05-23 |
CN1174574A (zh) | 1998-02-25 |
KR970707269A (ko) | 1997-12-01 |
US5965391A (en) | 1999-10-12 |
JPH10512742A (ja) | 1998-12-08 |
ZA959598B (en) | 1996-05-28 |
DE4440118C1 (de) | 1995-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4440118C1 (de) | Die Genexpression in coryneformen Bakterien regulierende DNA | |
EP2181195B1 (de) | Fermentative Gewinnung von Aceton aus erneuerbaren Rohstoffen mittels neuen Stoffwechselweges | |
DE69535674T2 (de) | Verfahren zur herstellung von l-valin und l-leucin | |
DE69233459T2 (de) | Herstellung von gamma-linolensäure durch eine delta-6 desaturase | |
JP7460179B2 (ja) | バイオレチノールを生産する微生物及びそれを用いたバイオレチノールの生産方法 | |
WO1998027201A2 (de) | Gene codierend für aminosäure-deacetylasen mit spezifität für n-acetyl-l-phosphinothricin, ihre isolierung und verwendung | |
JPS6371183A (ja) | ホスフィノトリシン耐性遺伝子及びその使用 | |
DE112011101574T9 (de) | Thioesterase und Verfahren zur Herstellung von Fettsäuren oder Lipiden unter Verwendung der Thioesterase | |
CN113667682B (zh) | Yh66-rs11190基因突变体及其在制备l-缬氨酸中的应用 | |
EP0667909B1 (de) | Biotechnologisches verfahren zur herstellung von biotin | |
Hornberger et al. | Cloning and sequencing of the hemA gene of Rhodobacter capsulatus and isolation of a δ-aminolevulinic acid-dependent mutant strain | |
EP0722500B1 (de) | Gene für den butyrobetain/crotonobetain-l-carnitin-stoffwechsel und ihre verwendung zur mikrobiologischen herstellung von l-carnitin | |
RU2136753C1 (ru) | Способ получения кобаламинов, плазмида (варианты), микроорганизм | |
EP0716699A1 (de) | Glycerin-3-phosphat-dehydrogenase (gpdh) | |
DE10006462B4 (de) | Produktion nicht-kariogener Zucker in transgenen Pflanzen | |
DE69736387T2 (de) | Biosynthese-verfahren zur herstellung von o-phospho-l-threonine | |
EP0524604B1 (de) | Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen | |
CN113801870A (zh) | SiLCYB调控番茄红素等谷子类胡萝卜素合成代谢的功能及应用 | |
EP0285949B1 (de) | Genetische Kontrolleinheit und Klonierungs- und Expressionssystem | |
EP0733704A2 (de) | Steuerbares Expressionssystem | |
WO1998010074A2 (de) | Adenylosuccinat synthetase | |
CN117616125A (zh) | 无毒素芦荟及其制备方法 | |
DE19632121C2 (de) | Transgene Pflanzenzellen und Pflanzen mit veränderter Acetyl-CoA-Bildung | |
EP0462892A1 (fr) | Souches de E.Coli productrices de vitamine B12 et procÀ©dé de préparation de la vitamine B12 par culture de ces souches | |
López-Lara et al. | Nodulation Efficiency nfe Gene Homolog of Agrobacterium Ornithine Cyclodeaminase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970515 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB IE IT NL SE |
|
17Q | First examination report despatched |
Effective date: 20010905 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: FORSCHUNGSZENTRUM JUELICH GMBH |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20030821 |